The DEPOT Study (Dry Eye Prescription Options for Therapy): Assessing the Efficacy and Safety of OTX-DED (Dexamethasone Ophthalmic Insert 0.3 mg) for Intracanalicular Use Compared with Loteprednol Suspension for the Treatment of Episodic Dry Eye

PURPOSE: To compare OTX-DED, an investigational dexamethasone intracanalicular insert, to loteprednol 0.5% suspension applied QID for 28 days as treatments for acute exacerbations of dry eye disease in terms of patient symptoms, corneal staining, tear breakup time (TBUT), and ocular redness. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: Hovanesian, John A, Keyser, Andrew, Berdy, Gregg, Sorensen, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9698338/
https://www.ncbi.nlm.nih.gov/pubmed/36438591
http://dx.doi.org/10.2147/OPTH.S387111

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9698338/
https://www.ncbi.nlm.nih.gov/pubmed/36438591
http://dx.doi.org/10.2147/OPTH.S387111

Ejemplares similares